The present invention generally relates to medical instruments, and more particularly, to embolic implants for aneurysm therapy.
Cranial aneurysms can be complicated and difficult to treat due to their proximity to critical brain tissues. Prior solutions have included endovascular treatment whereby an internal volume of the aneurysm sac is removed or excluded from arterial blood pressure and flow. Current alternatives to endovascular or other surgical approaches can include intravascularly delivered treatment devices that fill the sac of the aneurysm with embolic material or block the entrance or neck of the aneurysm. Both approaches attempt to prevent blood flow into the aneurysm. When filling an aneurysm sac, the embolic material clots the blood, creating a thrombotic mass within the aneurysm. When treating the aneurysm neck, blood flow into the entrance of the aneurysm is inhibited, inducing venous stasis in the aneurysm and facilitating a natural formation of a thrombotic mass within the aneurysm.
Current intravascularly delivered devices typically utilize multiple embolic coils to either fill the sac or treat the entrance of the aneurysm. Naturally formed thrombotic masses formed by treating the entrance with embolic coils can result in improved healing compared to aneurysm masses packed with embolic coils because naturally formed thrombotic masses can reduce the likelihood of distention from arterial walls and facilitate reintegration into the original parent vessel shape along the neck plane. However, embolic coils delivered to the neck of the aneurysm can potentially have the adverse effect of impeding the flow of blood in the adjoining blood vessel, particularly if the entrance is overpacked. Conversely, if the entrance is insufficiently packed, blood flow can persist into the aneurysm. Treating certain aneurysm morphology (e.g. wide neck, bifurcation, etc.) can require ancillary devices such a stents or balloons to support the coil mass and obtain the desired packing density. Once implanted, the coils cannot easily be retracted or repositioned. Furthermore, embolic coils do not always effectively treat aneurysms as aneurysms treated with multiple coils often recanalize or compact because of poor coiling, lack of coverage across the aneurysm neck, blood flow, or large aneurysm size.
Alternatives to embolic coils are being explored, for example a tubular braided implant is disclosed in U.S. Patent Publication Number 2018/0242979, incorporated herein by reference. Tubular braided implants have the potential to easily, accurately, and safely treat an aneurysm or other arterio-venous malformation in a parent vessel without blocking flow into perforator vessels communicating with the parent vessel. Compared to embolic coils, however, tubular braided implants are a newer technology, and there is therefore capacity for improved geometries, configurations, delivery systems, etc. for the tubular braided implants.
There is therefore a need for improved methods, devices, and systems for implants for aneurysm treatment.
It is an object of the present invention to provide systems, devices, and methods to meet the above-stated needs. Generally, it is an object of the present invention to provide a tubular braided implant including a braid that can be delivered as a single layer braid, can invert into itself during deployment to form at least two nested sacks, and can include additional braid material that can fill the innermost sack. The additional braid material can loop or coil like a ribbon and/or invert to form smaller and smaller nested sacks. In order to have an implant that can invert and fill an aneurysm, the braid can be made such that the distal end, the braid is made stronger, having a tendency to move toward a predetermined shape when implanted and forming the two nested sacks, and at the proximal end, the braid can be made weaker, having a tendency to flatten and fold in a ribbon shape inside of the sacks. The braid can have a variable braid angle along its length such that when positioned for delivery, the braid can have a high braid angle near its distal end and a low braid angle near the proximal end. In addition to the variable braid angle, or as an alternative, the braid can be heat treated to weaken the braid at the proximal end. In addition, or as a replacement for the braid material that fills the innermost sack, the implant can include an embolic coil that can loop within the innermost sack.
An example method for treating an aneurysm can include one or more of the following steps presented in no particular order. The example method can further include additional steps not listed here. A substantially tubular braid can be selected that has a first end, a second end, a first portion extending from the first end, and a second portion extending from the second end. The substantially tubular braid can be selected such that the braid, when in a single layer cylindrical shape having a uniform circumference along a length from one end of the braid to the other end of the braid, the braid has a smaller braid angle in the second portion of the braid compared to the first portion of the braid. The braid can be selected such that, when in the single layer cylindrical shape, the braid has a continuously decreasing braid angle extending from the first portion to the second portion.
The braid can be delivered through a microcatheter to an aneurysm. The braid can be delivered in the single layer tubular shape such that the first end is positioned in the distal direction in relation to the second end.
The first portion of the braid can be expanded to the aneurysm's wall. A proximal inversion can be formed in the braid at the aneurysm's neck. An inverted portion of the braid can be expanded to press into the expanded first portion. A distal inversion can be formed in the braid at a distal portion of the aneurysm's wall such that the inverted portion of the braid extends between the distal and proximal inversions.
The braid can be shaped to form a dome near the distal portion of the aneurysm's wall within the inverted portion. Additionally, or alternatively, the braid can be twisted at the distal inversion and the braid can be expanded to form a sack within the inverted portion.
The second portion of the braid can be positioned within the inverted portion, either directly in contact with the inverted portion, within sacks formed within the inverted portion, or otherwise positioned in the inverted portion. The second portion of the braid can be positioned such that the second portion is flattened and looped within the inverted portion.
An embolic coil can be selected. The embolic coil can be positioned such that it is affixed to the second end of the braid. The embolic coil can be delivered through the microcatheter to the aneurysm. The embolic coil can be positioned within the inverted portion of the implanted braid.
An example implant can include a tubular braid with two ends that is shapeable to a single layer cylindrical shape having a length measurable from one end to the other end, a substantially uniform circumference along the length, a larger braid angle on a first portion of the braid extending from a first of the two ends, and a smaller braid angel on a second portion of the braid extending from a second of the two ends. In the single layer cylindrical shape, the braid can have a continuously decreasing braid angle extending from the first portion to the second portion. In the single layer tubular shape, the braid can be sized to be delivered through a microcatheter to an aneurysm.
The braid can be movable from the single layer cylindrical shape to an implanted shape. In the implanted shape, the first portion can be positioned to appose an aneurysm wall, an inverted sack can be positioned to press the first portion to the aneurysm wall, and the second portion can be positioned within the inverted sack. In the implanted shape, at least a portion of the second portion of the braid can be looped within the inverted portion. In the implanted shape, the second portion can be positioned to press the inverted portion to the first portion.
In the implanted shape, an inner sack can be positioned to press the inverted sack to the first portion, the braid can have an inversion separating the inner sack and the inverted sack, and the braid can be twisted at the inversion.
In the implanted shape, the braid can have a dome shape within the inverted sack positioned near a distal portion of the aneurysm's wall.
The implant can further include an embolic coil affixed to the second end of the braid. In the implanted shape, the braid can be shaped to allow the embolic coil to be positioned within the inverted sack, either in direct contact with the inverted sack, separated from the inverted sack by braid material, or otherwise positioned in the inverted sack.
Another example implant can include a tubular braid having a first end and a second end. The braid can have a predetermined shape having two inversions dividing the braid into three segments: an outer segment extending from the first end to a first inversion of the two inversions, a middle segment extending between the two inversions and at least partially surrounded by the outer segment, and an inner segment extending from the second of the two inversions to the second end and at least partially surrounded by the middle segment. In the predetermined shape, the braid can have an abrupt change in braid angle at a position on the inner segment such that a distal portion of the inner segment extending from the second inversion has a higher braid angle than a proximal portion of the inner segment extending from the second end.
The braid can be movable to an implanted shape sized to be positioned within an aneurysm sac. In the implanted shape, a part of the braid corresponding to the inner segment in the predetermined shape can be collapsed to a ribbon shape and positioned in an inverted sack formed from a part of the braid corresponding to the middle segment in the predetermined shape.
The braid can be shaped to a single layer cylindrical shape having a substantially uniform circumference between the two ends of the braid, a larger braid angle in a first portion of the braid extending from the first end, and a smaller braid angle in a second portion of the braid extending from the second end. In the single layer cylindrical shape, the braid can have a continuously decreasing braid angle from the first portion to the second portion. In the single layer cylindrical shape, the braid can be sized to be delivered through a microcatheter to an aneurysm.
The above and further aspects of this invention are further discussed with reference to the following description in conjunction with the accompanying drawings, in which like numerals indicate like structural elements and features in various figures. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the invention. The figures depict one or more implementations of the inventive devices, by way of example only, not by way of limitation.
In known treatments of wide neck aneurysms, the aneurysm is typically treated by placing embolic coils within the aneurysm sac and placing a stent within the parent blood vessel across the aneurysm neck. The stent is necessary in many cases to inhibit the embolic coils from entering the parent blood vessel. If embolic coils enter the parent blood vessel, the coils can obstruct the vessel and/or clots can form on the coils within the blood vessel and create an obstruction in the parent blood vessel. Braided aneurysm intrasaccular implants can be used to treat wide neck aneurysms without requiring a stent to secure the braided implant at the aneurysm neck. However, to achieve the forces necessarily to anchor braided implants in a wide neck bifurcation, the braid can be stiff and resistant to reshaping to an implanted shape that is significantly different than a predetermined shape. It can therefore be challenging, in some cases, to pack the aneurysm with a sufficient braid density to quickly and effectively induce blood stasis within the aneurysm sac. A braid made too soft can compact in shape and cause the aneurysm to recanalize as the implant is no longer sealing the neck of the aneurysm.
Aspects of the present invention are directed to address the above challenges. In examples presented herein, a tubular braided implant can include a braid that can be delivered as a single layer braid, can invert into itself during deployment to form at least two nested sacks, and can include additional braid material that can fill the innermost sack. The additional braid material can loop or coil like a ribbon and/or invert to form smaller and smaller nested sacks. An aspect of the present invention is to provide a structure that allows a sufficient amount of additional braid material to be placed into the innermost sack such that the aneurysm clots quickly for an effective treatment.
When used herein, the terms “tubular” and “tube” are to be construed broadly and are not limited to a structure that is a right cylinder or strictly circumferential in cross-section or of a uniform cross-section throughout its length. For simplicity, tubular structures are generally illustrated herein as having a substantially right cylindrical structure. However, a tubular structure can have a tapered or curved outer surface without departing from the scope of the present invention.
To meet the competing needs for braid stiffness to achieve secure anchoring within the aneurysm and braid softness to deform the braid to a high packing density within the aneurysm, the braid can be made such that portions of the braid pushed into the aneurysm when the aneurysm has a higher packing density are weaker compared to stiffer portions of the braid that expand to anchor the braid within the aneurysm. Stiffness/flexibility of the braid portions can be controlled by braid angle (e.g. picks per inch), strand diameter, number of strands, material of strands, and/or treatment (e.g. heat treatment) to modify strand material properties, etc. A stiffer portion can have a higher braid angle, a larger strand diameter, more strands, strands comprising a stiffer material, and/or strands treated to have greater stiffness compared to a weaker portion.
Stiffer portions of the braid can be positioned near a distal end of the braid when the braid is being delivered through a catheter so that the stiffer portions of the braid exit the catheter and expand to anchor in the aneurysm before the aneurysm is packed. Stiffer portions of the braid can be shaped in a predetermined shape by heat setting or other means such that when the stiffer portions, they expand toward the predetermined shape. The tendency of the stiffer portions of the braid to expand toward the predetermined shape can create sufficient force against the aneurysm walls to anchor the braid in the aneurysm sac. Weaker portions of the braid can be positioned near the proximal end of the braid when the braid is delivered through the catheter. Portions of the braid which have the most flexibility can be dynamically deformed to loop or nest within the aneurysm, folding within the stiffer, anchoring portions of braid.
In addition, or as a replacement for the braid material that fills the innermost sack, the implant can include an embolic coil that can loop within the innermost sack.
Examples presented herein generally include a braided implant that can secure within an aneurysm sac and occlude a majority of the aneurysm's neck. The implant can include a tubular braid having a stiffer portion and a weaker portion, at least the stiffer portion being set into a predetermined shape, the braid being compressible for delivery through a microcatheter, and the braid being implantable in an implanted position that is based on the geometry of the aneurysm in which the braid is implanted and based at least in part on the predetermined shape.
An example implant 100, as illustrated in
In the single layer tubular shape illustrated in
The braid can include a number of strands, for example, from about 4 to about 96 strands, each extending from one braid end 112 to the other 114. As used herein, the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. More specifically, “about” or “approximately” may refer to the range of values ±20% of the recited value, e.g. “about 90%” may refer to the range of values from 71% to 99%. The strands can wrap helically around the circumference C. The number of strands, angle of strands, diameter of the strands, material of strands, and material properties of strands, can all be factors in controlling material properties of the braid 110, including porosity and flexibility. Braid strands can be woven such that about half of the strands wrap in a clockwise helix, the other half wraps in a counterclockwise helix, and the oppositely wrapping strands cross over and under each other in an alternating fashion. Constructed as such, portions of the braid having a higher braid angle can therefore having a higher density of strands compared to portions of the braid having lower braid angle. Higher strand density can result in a denser, stiffer braid portion.
The strands can be made from multiple alloys such as a nickel-titanium alloy, cobalt chromium alloys, platinum, nitinol, stainless steel, tantalum, or other alloys, or any other suitable biocompatible materials, or combination of these materials. Also, these materials can be absorbable or non-absorbable by the patient over time. Some or all of braid 110 can be a multi-filament cylindrical mesh made preferably of nitinol with interwoven platinum filaments for radiopacity or Drawn Filled Tube (DFT) Nitinol with about 10 to about 40% platinum. The apertures in the mesh of braid 110 can also create a substantially unitary frame work or mesh. Thus, the apertures can have variable size, shape, or porosity, and may be uniformly or randomly spaced throughout the wall of the mesh of braid 110. The apertures can provide the braid 110 with flexibility and also assist in the transformation of the braid from the collapsed state to the expanded, deployed state, and vice versa.
The braid 110 as illustrated in
The implant 100 can be delivered to an aneurysm when the braid 110 is sized to traverse a catheter. For instance, the braid 110 can be delivered in the single-layer tubular shape as illustrated in
In the predetermined shape, the braid 110 can include two inversions 122, 124 and a pinch point 126 dividing the braid 110 into four segments 142, 144, 146, 130. In the predetermined shape, the braid 110 can have an outer segment 142 extending from the open end 114 of the braid 110 to a first inversion 122 of the two inversions 122, 124, a middle segment 144 extending between the two inversions 122, 124, an inner segment 146 extending from a second inversion 124 of the two inversions 122, 124 to the pinched point 126 of the braid 110, and an elongated section 130 extending from the pinch point 126 to an opposite end 112 of the braid 110. When in the predetermined shape, the tubular braid 110 can be substantially radially symmetrical around a central vertical axis y.
The tubular braid 110 can be formed into the predetermined shape by first pinching the braid 110 at the pinch point 126, then inverting the braid outwardly to separate the inner segment 146 from the middle segment 144 with an inversion 124, then shaping the middle segment 144 over a form to produce the substantially “S” shaped profile illustrated, and finally, inverting the braid 110 outwardly again to separate the middle segment 144 from the outer segment 142 with another inversion 122. Optionally, the braid can be trimmed at the open end 114 and/or the proximal end 112. The open end 114 can be positioned to encircle the middle segment 144. The open end 114 can positioned within the middle third section of the braid's height as illustrated. Alternatively, the open end 114 can be positioned elsewhere, such as near the distal inversion 124.
The outer sack 142 can correspond to the distal portion 118 of the braid 110 as illustrated in
Alternatively, sections 142, 144, 146 distal to the pinch point 126 can have a high braid angle θ1 that is consistent along the length of those sections 142, 144, 146 when the braid 110 is in a single layer tubular shape, the tail section 130 can have a low braid angle θ4 consistent along its length, and the braid 110 can have an abrupt change in braid angle at the pinch point 126. The tail 130 can be sufficiently flexible such that, when manipulated at an intravascular treatment site, it flattens to a ribbon shape and folds onto itself. Alternatively, braid 110 can include an abrupt braid angle change at the proximal inflection 122, at the distal inflection 124, at the pinch point 126, or any combination thereof.
Strands of the braid 110 at the open end 114 can be free, cut ends; or, alternatively, the strands at the open end 114 be closed, meaning strands within the braid at the open end 114 are attached to each other by glue, weld, etc. or the strands bend back at the open end 114. Free cut ends can have an advantage of being easier to manufacture while the closed strand ends can have an advantage of being more atraumatic compared to the cut ends.
Referring to method 300 outlined in
In step 304, the braid can be delivered through a microcatheter to an aneurysm. The braid can be detachably attached to an elongated delivery system. The implant (and thereby the braid) can be attached to the delivery system at a distal end of the delivery system. The delivery system and the implant can be positioned within the microcatheter such that the delivery system extends from a proximal end of the microcatheter. A user (e.g. physician) can deliver the implant through the microcatheter by manipulating the portion of the delivery system that extends out of the proximal end of the microcatheter. A user can place the implant similar to as illustrated in
In step 306, the distal end of the braid can be positioned at a distal portion 15 of the aneurysm wall 14. The distal end of the braid can be positioned as illustrated in
In step 308, the stronger section of the braid can be expanded to form an outer sack apposing the aneurysm wall 14. The outer sack can be shaped similar to the outer sack 142′ illustrated in
In step 310, a proximal inversion can be formed in the braid at the aneurysm's neck. The proximal inversion can be positioned similar to the proximal inversion 122′ illustrated in
In step 312, the inverted portion can be expanded to form a sack inside the outer sack or outer section. The inverted portion can press against the outer sack (or section), thereby pressing the outer sack (or section) into the aneurysm wall 14. The inverted portion can form an inner sack 144′ such as illustrated in
In step 314, a distal inversion can be formed in the braid. The distal inversion can define a distal side of the inverted, inner sack expanded in step 312. The distal inversion can define a boundary between the inner sack and an inner, non-inverted portion of the braid. The inner, non-inverted portion of the braid can include the weaker section of the braid.
In step 316, the weaker section of the braid can be positioned in the inverted sack. The weaker section can be flattened to a ribbon shape and folded into the inverted sack. The weaker section can be flattened and folded such as illustrated in
The descriptions contained herein are examples of embodiments of the invention and are not intended in any way to limit the scope of the invention. The invention contemplates many variations and modifications of the implant, including: alternative delivery methods, alternative braid materials, alternative means for achieving a desired stiffness/flexibility of braid material, additional structures affixed to the implant (e.g. to aid in anchoring the implant, blood flow diversion, embolism formation, etc.), alternative predetermined braid shapes (e.g. one inversion, three inversions, four inversions, five or more inversions, non-radially symmetric shapes, alternative segment shapes, etc.), alternative implanted shapes, etc. Modifications apparent to one of ordinary skill in the art following the teachings of this disclosure are intended to be within the scope of the claims which follow.
Number | Name | Date | Kind |
---|---|---|---|
2849002 | Oddo | Aug 1958 | A |
3480017 | Shute | Nov 1969 | A |
4085757 | Pevsner | Apr 1978 | A |
4282875 | Serbinenko et al. | Apr 1981 | A |
4364392 | Strother et al. | Dec 1982 | A |
4395806 | Wonder et al. | Aug 1983 | A |
4517979 | Pecenka | May 1985 | A |
4545367 | Tucci | Oct 1985 | A |
4836204 | Landymore et al. | Jun 1989 | A |
4991602 | Amplatz et al. | Feb 1991 | A |
5002556 | Ishida et al. | Mar 1991 | A |
5025060 | Yabuta et al. | Jun 1991 | A |
5065772 | Cox, Jr. | Nov 1991 | A |
5067489 | Lind | Nov 1991 | A |
5122136 | Guglielmi et al. | Jun 1992 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5261916 | Engelson | Nov 1993 | A |
5304195 | Twyford, Jr. et al. | Apr 1994 | A |
5334210 | Gianturco | Aug 1994 | A |
5350397 | Palermo | Sep 1994 | A |
5423829 | Pham et al. | Jun 1995 | A |
5624449 | Pham et al. | Apr 1997 | A |
5645558 | Horton | Jul 1997 | A |
5733294 | Forber et al. | Mar 1998 | A |
5891128 | Gia et al. | Apr 1999 | A |
5916235 | Guglielmi | Jun 1999 | A |
5928260 | Chin et al. | Jul 1999 | A |
5935148 | Villar | Aug 1999 | A |
5941249 | Maynard | Aug 1999 | A |
5951599 | McCrory | Sep 1999 | A |
5964797 | Ho | Oct 1999 | A |
6007573 | Wallace et al. | Dec 1999 | A |
6024756 | Pham | Feb 2000 | A |
6036720 | Abrams | Mar 2000 | A |
6063070 | Eder | May 2000 | A |
6063100 | Diaz et al. | May 2000 | A |
6063104 | Villar | May 2000 | A |
6080191 | Thaler | Jun 2000 | A |
6086577 | Ken et al. | Jul 2000 | A |
6096021 | Helm et al. | Aug 2000 | A |
6113609 | Adams | Sep 2000 | A |
6123714 | Gia et al. | Sep 2000 | A |
6168615 | Ken | Jan 2001 | B1 |
6168622 | Mazzocchi | Jan 2001 | B1 |
6193708 | Ken et al. | Feb 2001 | B1 |
6221086 | Forber | Apr 2001 | B1 |
6270515 | Linden et al. | Aug 2001 | B1 |
6315787 | Tsugita et al. | Nov 2001 | B1 |
6331184 | Abrams | Dec 2001 | B1 |
6334048 | Edvardsson et al. | Dec 2001 | B1 |
6346117 | Greenhalgh | Feb 2002 | B1 |
6350270 | Roue | Feb 2002 | B1 |
6375606 | Garbaldi et al. | Apr 2002 | B1 |
6375668 | Gifford | Apr 2002 | B1 |
6379329 | Naglreiter et al. | Apr 2002 | B1 |
6391037 | Greenhalgh | May 2002 | B1 |
6419686 | McLeod et al. | Jul 2002 | B1 |
6428558 | Jones | Aug 2002 | B1 |
6454780 | Wallace | Sep 2002 | B1 |
6463317 | Kucharczyk et al. | Oct 2002 | B1 |
6506204 | Mazzocchi et al. | Jan 2003 | B2 |
6527919 | Roth | Mar 2003 | B1 |
6547804 | Porter et al. | Apr 2003 | B2 |
6551303 | Van Tassel et al. | Apr 2003 | B1 |
6569179 | Teoh | May 2003 | B2 |
6569190 | Whalen, II et al. | May 2003 | B2 |
6572628 | Dominguez | Jun 2003 | B2 |
6589230 | Gia et al. | Jul 2003 | B2 |
6589256 | Forber | Jul 2003 | B2 |
6605102 | Mazzocchi et al. | Aug 2003 | B1 |
6620152 | Guglielmi | Sep 2003 | B2 |
6669719 | Wallace et al. | Dec 2003 | B2 |
6689159 | Lau et al. | Feb 2004 | B2 |
6746468 | Sepetka | Jun 2004 | B1 |
6780196 | Chin et al. | Aug 2004 | B2 |
6802851 | Jones | Oct 2004 | B2 |
6811560 | Jones | Nov 2004 | B2 |
6833003 | Jones et al. | Dec 2004 | B2 |
6846316 | Abrams | Jan 2005 | B2 |
6849081 | Sepetka et al. | Feb 2005 | B2 |
6855154 | Abdel-Gawwad | Feb 2005 | B2 |
6949116 | Solymar et al. | Sep 2005 | B2 |
6964657 | Cragg et al. | Nov 2005 | B2 |
6964671 | Cheng | Nov 2005 | B2 |
6994711 | Hieshima et al. | Feb 2006 | B2 |
7044134 | Khairkhahan et al. | May 2006 | B2 |
7083632 | Avellanet | Aug 2006 | B2 |
7093527 | Rapaport et al. | Aug 2006 | B2 |
7128736 | Abrams et al. | Oct 2006 | B1 |
7152605 | Khairkhahan et al. | Dec 2006 | B2 |
7153323 | Teoh | Dec 2006 | B1 |
7195636 | Avellanet et al. | Mar 2007 | B2 |
7229454 | Tran et al. | Jun 2007 | B2 |
7229461 | Chin et al. | Jun 2007 | B2 |
7309345 | Wallace | Dec 2007 | B2 |
7371249 | Douk et al. | May 2008 | B2 |
7377932 | Mitelberg et al. | May 2008 | B2 |
7410482 | Murphy et al. | Aug 2008 | B2 |
7572288 | Cox | Aug 2009 | B2 |
7597704 | Frazier et al. | Oct 2009 | B2 |
7608088 | Jones | Oct 2009 | B2 |
7695488 | Berenstein et al. | Apr 2010 | B2 |
7713264 | Murphy | May 2010 | B2 |
7744652 | Morsi | Jun 2010 | B2 |
7892248 | Tran | Feb 2011 | B2 |
7985238 | Balgobin et al. | Jul 2011 | B2 |
RE42758 | Ken | Sep 2011 | E |
8016852 | Ho | Sep 2011 | B2 |
8021416 | Abrams | Sep 2011 | B2 |
8025668 | McCartney | Sep 2011 | B2 |
8034061 | Amplatz et al. | Oct 2011 | B2 |
8048145 | Evans et al. | Nov 2011 | B2 |
8062325 | Mitelberg et al. | Nov 2011 | B2 |
8075585 | Lee et al. | Dec 2011 | B2 |
8142456 | Rosqueta et al. | Mar 2012 | B2 |
8221483 | Ford et al. | Jul 2012 | B2 |
8261648 | Marchand et al. | Sep 2012 | B1 |
8267923 | Murphy | Sep 2012 | B2 |
8361106 | Solar et al. | Jan 2013 | B2 |
8361138 | Adams | Jan 2013 | B2 |
8372114 | Hines | Feb 2013 | B2 |
8398671 | Chen | Mar 2013 | B2 |
8430012 | Marchand | Apr 2013 | B1 |
8454633 | Amplatz et al. | Jun 2013 | B2 |
8523897 | van der Burg et al. | Sep 2013 | B2 |
8523902 | Heaven et al. | Sep 2013 | B2 |
8551132 | Eskridge et al. | Oct 2013 | B2 |
8777974 | Amplatz et al. | Jul 2014 | B2 |
8900304 | Alobaid | Dec 2014 | B1 |
8974512 | Aboytes et al. | Mar 2015 | B2 |
8992568 | Duggal et al. | Mar 2015 | B2 |
8998947 | Aboytes et al. | Apr 2015 | B2 |
9055948 | Jaeger et al. | Jun 2015 | B2 |
9107670 | Hannes et al. | Aug 2015 | B2 |
9161758 | Figulla et al. | Oct 2015 | B2 |
9232992 | Heidner et al. | Jan 2016 | B2 |
9259337 | Cox et al. | Feb 2016 | B2 |
9314326 | Wallace et al. | Apr 2016 | B2 |
9351715 | Mach | May 2016 | B2 |
9414842 | Glimsdale et al. | Aug 2016 | B2 |
9526813 | Cohn et al. | Dec 2016 | B2 |
9532792 | Galdonik et al. | Jan 2017 | B2 |
9532873 | Kelley | Jan 2017 | B2 |
9533344 | Monetti et al. | Jan 2017 | B2 |
9539011 | Chen et al. | Jan 2017 | B2 |
9539022 | Bowman | Jan 2017 | B2 |
9539122 | Burke et al. | Jan 2017 | B2 |
9539382 | Nelson | Jan 2017 | B2 |
9549830 | Bruszewski et al. | Jan 2017 | B2 |
9554805 | Tompkins et al. | Jan 2017 | B2 |
9561096 | Kim et al. | Feb 2017 | B2 |
9561125 | Bowman et al. | Feb 2017 | B2 |
9572982 | Burnes et al. | Feb 2017 | B2 |
9579104 | Beckham et al. | Feb 2017 | B2 |
9579484 | Barnell | Feb 2017 | B2 |
9585642 | Dinsmoor et al. | Mar 2017 | B2 |
9585669 | Becking et al. | Mar 2017 | B2 |
9615832 | Bose et al. | Apr 2017 | B2 |
9615951 | Bennett et al. | Apr 2017 | B2 |
9622753 | Cox | Apr 2017 | B2 |
9629635 | Hewitt et al. | Apr 2017 | B2 |
9636115 | Henry et al. | May 2017 | B2 |
9636439 | Chu et al. | May 2017 | B2 |
9642675 | Werneth et al. | May 2017 | B2 |
9655633 | Leynov et al. | May 2017 | B2 |
9655645 | Staunton | May 2017 | B2 |
9655989 | Cruise et al. | May 2017 | B2 |
9662129 | Galdonik et al. | May 2017 | B2 |
9662238 | Dwork et al. | May 2017 | B2 |
9662425 | Lilja et al. | May 2017 | B2 |
9668898 | Wong | Jun 2017 | B2 |
9675477 | Thompson | Jun 2017 | B2 |
9675782 | Connolly | Jun 2017 | B2 |
9676022 | Ensign et al. | Jun 2017 | B2 |
9681861 | Heisel et al. | Jun 2017 | B2 |
9692557 | Murphy | Jun 2017 | B2 |
9693852 | Lam et al. | Jul 2017 | B2 |
9700262 | Janik et al. | Jul 2017 | B2 |
9700399 | Acosta-Acevedo | Jul 2017 | B2 |
9717421 | Griswold et al. | Aug 2017 | B2 |
9717500 | Tieu et al. | Aug 2017 | B2 |
9717502 | Teoh et al. | Aug 2017 | B2 |
9724103 | Cruise et al. | Aug 2017 | B2 |
9724526 | Strother et al. | Aug 2017 | B2 |
9750565 | Bloom et al. | Sep 2017 | B2 |
9757260 | Greenan | Sep 2017 | B2 |
9764111 | Gulachenski | Sep 2017 | B2 |
9770251 | Bowman et al. | Sep 2017 | B2 |
9770577 | Li et al. | Sep 2017 | B2 |
9775621 | Tompkins et al. | Oct 2017 | B2 |
9775706 | Peterson et al. | Oct 2017 | B2 |
9775732 | Khenansho | Oct 2017 | B2 |
9788800 | Mayoras, Jr. | Oct 2017 | B2 |
9795391 | Saatchi et al. | Oct 2017 | B2 |
9801980 | Karino et al. | Oct 2017 | B2 |
9808599 | Bowman et al. | Nov 2017 | B2 |
9826980 | Figulla et al. | Nov 2017 | B2 |
9833252 | Sepetka et al. | Dec 2017 | B2 |
9833604 | Lam et al. | Dec 2017 | B2 |
9833625 | Waldhauser et al. | Dec 2017 | B2 |
9918720 | Marchand et al. | Mar 2018 | B2 |
9955976 | Hewitt et al. | May 2018 | B2 |
10004510 | Gerberding | Jun 2018 | B2 |
10130372 | Griffin | Nov 2018 | B2 |
10307148 | Heisel et al. | Jun 2019 | B2 |
10327781 | Divino et al. | Jun 2019 | B2 |
10342546 | Sepetka et al. | Jul 2019 | B2 |
10517604 | Bowman et al. | Dec 2019 | B2 |
10653425 | Gorochow et al. | May 2020 | B1 |
10716573 | Connor | Jul 2020 | B2 |
10743884 | Lorenzo | Aug 2020 | B2 |
10751066 | Lorenzo | Aug 2020 | B2 |
11464518 | Connor | Oct 2022 | B2 |
20020068974 | Kuslich et al. | Jun 2002 | A1 |
20020082638 | Porter et al. | Jun 2002 | A1 |
20020143349 | Gifford, III et al. | Oct 2002 | A1 |
20020147497 | Belef et al. | Oct 2002 | A1 |
20020188314 | Anderson et al. | Dec 2002 | A1 |
20030028209 | Teoh et al. | Feb 2003 | A1 |
20030120337 | Van Tassel et al. | Jun 2003 | A1 |
20030171739 | Murphy et al. | Sep 2003 | A1 |
20030176884 | Berrada et al. | Sep 2003 | A1 |
20030181927 | Wallace | Sep 2003 | A1 |
20030181945 | Opolski | Sep 2003 | A1 |
20030195553 | Wallace | Oct 2003 | A1 |
20030216772 | Konya | Nov 2003 | A1 |
20040034366 | van der Burg et al. | Feb 2004 | A1 |
20040034386 | Fulton et al. | Feb 2004 | A1 |
20040044391 | Porter | Mar 2004 | A1 |
20040087998 | Lee et al. | May 2004 | A1 |
20040098027 | Teoh et al. | May 2004 | A1 |
20040127935 | Van Tassel et al. | Jul 2004 | A1 |
20040133222 | Tran et al. | Jul 2004 | A1 |
20040153120 | Seifert et al. | Aug 2004 | A1 |
20040210297 | Lin et al. | Oct 2004 | A1 |
20040254594 | Alfaro | Dec 2004 | A1 |
20050021016 | Malecki et al. | Jan 2005 | A1 |
20050021072 | Wallace | Jan 2005 | A1 |
20050159771 | Petersen | Jul 2005 | A1 |
20050177103 | Hunter et al. | Aug 2005 | A1 |
20050251200 | Porter | Nov 2005 | A1 |
20060052816 | Bates et al. | Mar 2006 | A1 |
20060058735 | Lesh | Mar 2006 | A1 |
20060064151 | Guterman et al. | Mar 2006 | A1 |
20060106421 | Teoh | May 2006 | A1 |
20060155323 | Porter et al. | Jul 2006 | A1 |
20060155367 | Hines | Jul 2006 | A1 |
20060167494 | Suddaby | Jul 2006 | A1 |
20060247572 | McCartney | Nov 2006 | A1 |
20070088387 | Eskridge et al. | Apr 2007 | A1 |
20070106311 | Wallace et al. | May 2007 | A1 |
20070208376 | Meng | Jun 2007 | A1 |
20070162071 | Burkett et al. | Jul 2007 | A1 |
20070167876 | Euteneuer et al. | Jul 2007 | A1 |
20070173928 | Morsi | Jul 2007 | A1 |
20070186933 | Domingo | Aug 2007 | A1 |
20070191884 | Eskridge et al. | Aug 2007 | A1 |
20070233188 | Hunt et al. | Oct 2007 | A1 |
20070265656 | Amplatz et al. | Nov 2007 | A1 |
20070288083 | Hines | Dec 2007 | A1 |
20080097495 | Feller, III et al. | Apr 2008 | A1 |
20080103505 | Fransen | May 2008 | A1 |
20080119886 | Greenhalgh et al. | May 2008 | A1 |
20080281350 | Sepetka et al. | Nov 2008 | A1 |
20090036877 | Nardone et al. | Feb 2009 | A1 |
20090062841 | Amplatz et al. | Mar 2009 | A1 |
20090099647 | Glimsdale | Apr 2009 | A1 |
20090227983 | Griffin et al. | Sep 2009 | A1 |
20090281557 | Sander et al. | Nov 2009 | A1 |
20090287291 | Becking et al. | Nov 2009 | A1 |
20090287294 | Rosqueta et al. | Nov 2009 | A1 |
20090287297 | Cox | Nov 2009 | A1 |
20090318941 | Sepetka | Dec 2009 | A1 |
20100023046 | Heidner et al. | Jan 2010 | A1 |
20100023048 | Mach | Jan 2010 | A1 |
20100063573 | Hijlkema | Mar 2010 | A1 |
20100063582 | Rudakov | Mar 2010 | A1 |
20100069948 | Veznedaroglu et al. | Mar 2010 | A1 |
20100168781 | Berenstein | Jul 2010 | A1 |
20100211156 | Linder et al. | Aug 2010 | A1 |
20100324649 | Mattsson et al. | Dec 2010 | A1 |
20110046658 | Conner et al. | Feb 2011 | A1 |
20110054519 | Neuss | Mar 2011 | A1 |
20110112588 | Linderman et al. | May 2011 | A1 |
20110137317 | O'Halloran et al. | Jun 2011 | A1 |
20110152993 | Marchand et al. | Jun 2011 | A1 |
20110196413 | Wallace | Aug 2011 | A1 |
20110319978 | Schaffer | Dec 2011 | A1 |
20120010644 | Sideris et al. | Jan 2012 | A1 |
20120071911 | Sadasivan | Mar 2012 | A1 |
20120165732 | Müller | Jun 2012 | A1 |
20120191123 | Brister et al. | Jul 2012 | A1 |
20120283768 | Cox et al. | Nov 2012 | A1 |
20120310270 | Murphy | Dec 2012 | A1 |
20120323267 | Ren | Dec 2012 | A1 |
20120330341 | Becking et al. | Dec 2012 | A1 |
20130035665 | Chu | Feb 2013 | A1 |
20130035712 | Theobald et al. | Feb 2013 | A1 |
20130066357 | Aboytes et al. | Mar 2013 | A1 |
20130079864 | Boden | Mar 2013 | A1 |
20130110066 | Sharma et al. | May 2013 | A1 |
20130204351 | Cox et al. | Aug 2013 | A1 |
20130211495 | Halden et al. | Aug 2013 | A1 |
20130261658 | Lorenzo et al. | Oct 2013 | A1 |
20130261730 | Bose et al. | Oct 2013 | A1 |
20130274863 | Cox et al. | Oct 2013 | A1 |
20130345738 | Eskridge | Dec 2013 | A1 |
20140005714 | Quick | Jan 2014 | A1 |
20140012307 | Franano et al. | Jan 2014 | A1 |
20140012363 | Franano et al. | Jan 2014 | A1 |
20140018838 | Franano et al. | Jan 2014 | A1 |
20140135812 | Divino et al. | May 2014 | A1 |
20140200607 | Sepetka | Jul 2014 | A1 |
20140257360 | Keillor | Sep 2014 | A1 |
20140257361 | Prom | Sep 2014 | A1 |
20140277013 | Sepetka et al. | Sep 2014 | A1 |
20140358178 | Hewitt et al. | Dec 2014 | A1 |
20150057703 | Ryan | Feb 2015 | A1 |
20150209050 | Aboytes et al. | Jul 2015 | A1 |
20150272589 | Lorenzo | Oct 2015 | A1 |
20150313605 | Griffin | Nov 2015 | A1 |
20150342613 | Aboytes et al. | Dec 2015 | A1 |
20150374483 | Janardhan | Dec 2015 | A1 |
20160022445 | Ruvalcaba et al. | Jan 2016 | A1 |
20160030050 | Franano et al. | Feb 2016 | A1 |
20160192912 | Kassab et al. | Jul 2016 | A1 |
20160249934 | Hewitt et al. | Sep 2016 | A1 |
20160249935 | Hewitt et al. | Sep 2016 | A1 |
20170007264 | Cruise et al. | Jan 2017 | A1 |
20170007265 | Guo et al. | Jan 2017 | A1 |
20170020670 | Murray et al. | Jan 2017 | A1 |
20170020700 | Bienvenu et al. | Jan 2017 | A1 |
20170027640 | Kunis et al. | Feb 2017 | A1 |
20170027692 | Bonhoeffer et al. | Feb 2017 | A1 |
20170027725 | Argentine | Feb 2017 | A1 |
20170035436 | Morita | Feb 2017 | A1 |
20170035567 | Duffy | Feb 2017 | A1 |
20170042548 | Lam | Feb 2017 | A1 |
20170049596 | Schabert | Feb 2017 | A1 |
20170071737 | Kelley | Mar 2017 | A1 |
20170072452 | Monetti et al. | Mar 2017 | A1 |
20170079661 | Bardsley et al. | Mar 2017 | A1 |
20170079662 | Rhee et al. | Mar 2017 | A1 |
20170079671 | Morero et al. | Mar 2017 | A1 |
20170079680 | Bowman | Mar 2017 | A1 |
20170079717 | Walsh et al. | Mar 2017 | A1 |
20170079766 | Wang et al. | Mar 2017 | A1 |
20170079767 | Leon-Yip | Mar 2017 | A1 |
20170079812 | Lam et al. | Mar 2017 | A1 |
20170079817 | Sepetka et al. | Mar 2017 | A1 |
20170079819 | Pung et al. | Mar 2017 | A1 |
20170079820 | Lam et al. | Mar 2017 | A1 |
20170086851 | Wallace et al. | Mar 2017 | A1 |
20170086996 | Peterson et al. | Mar 2017 | A1 |
20170095259 | Tompkins et al. | Apr 2017 | A1 |
20170100126 | Bowman et al. | Apr 2017 | A1 |
20170100141 | Morero et al. | Apr 2017 | A1 |
20170100143 | Granfield | Apr 2017 | A1 |
20170100183 | Iaizzo et al. | Apr 2017 | A1 |
20170113023 | Steingisser et al. | Apr 2017 | A1 |
20170147765 | Mehta | May 2017 | A1 |
20170151032 | Loisel | Jun 2017 | A1 |
20170165062 | Rothstein | Jun 2017 | A1 |
20170165065 | Rothstein et al. | Jun 2017 | A1 |
20170165454 | Tuohy et al. | Jun 2017 | A1 |
20170172581 | Bose et al. | Jun 2017 | A1 |
20170172766 | Vong et al. | Jun 2017 | A1 |
20170172772 | Khenansho | Jun 2017 | A1 |
20170189033 | Sepetka et al. | Jul 2017 | A1 |
20170189035 | Porter | Jul 2017 | A1 |
20170114350 | Shimizu et al. | Aug 2017 | A1 |
20170215902 | Leynov et al. | Aug 2017 | A1 |
20170216484 | Cruise et al. | Aug 2017 | A1 |
20170224350 | Shimizu et al. | Aug 2017 | A1 |
20170224355 | Bowman et al. | Aug 2017 | A1 |
20170224467 | Piccagli et al. | Aug 2017 | A1 |
20170224511 | Dwork et al. | Aug 2017 | A1 |
20170224953 | Tran et al. | Aug 2017 | A1 |
20170231749 | Perkins et al. | Aug 2017 | A1 |
20170252064 | Staunton | Sep 2017 | A1 |
20170258473 | Plaza et al. | Sep 2017 | A1 |
20170265983 | Lam et al. | Sep 2017 | A1 |
20170281192 | Tieu et al. | Oct 2017 | A1 |
20170281331 | Perkins et al. | Oct 2017 | A1 |
20170281344 | Costello | Oct 2017 | A1 |
20170281909 | Northrop et al. | Oct 2017 | A1 |
20170281912 | Melder et al. | Oct 2017 | A1 |
20170290593 | Cruise et al. | Oct 2017 | A1 |
20170290654 | Sethna | Oct 2017 | A1 |
20170296324 | Argentine | Oct 2017 | A1 |
20170296325 | Marrocco et al. | Oct 2017 | A1 |
20170303939 | Greenhalgh et al. | Oct 2017 | A1 |
20170303942 | Greenhalgh et al. | Oct 2017 | A1 |
20170303947 | Greenhalgh et al. | Oct 2017 | A1 |
20170303948 | Wallace et al. | Oct 2017 | A1 |
20170304041 | Argentine | Oct 2017 | A1 |
20170304097 | Corwin et al. | Oct 2017 | A1 |
20170304595 | Nagasrinivasa et al. | Oct 2017 | A1 |
20170312109 | Le | Nov 2017 | A1 |
20170312484 | Shipley et al. | Nov 2017 | A1 |
20170316561 | Helm et al. | Nov 2017 | A1 |
20170319826 | Bowman et al. | Nov 2017 | A1 |
20170333228 | Orth et al. | Nov 2017 | A1 |
20170333236 | Greenan | Nov 2017 | A1 |
20170333678 | Bowman et al. | Nov 2017 | A1 |
20170340333 | Badruddin et al. | Nov 2017 | A1 |
20170340383 | Bloom et al. | Nov 2017 | A1 |
20170348014 | Wallace et al. | Dec 2017 | A1 |
20170348514 | Guyon et al. | Dec 2017 | A1 |
20180140305 | Connor | May 2018 | A1 |
20180206850 | Wang et al. | Jul 2018 | A1 |
20180242979 | Lorenzo | Aug 2018 | A1 |
20180303531 | Sanders et al. | Oct 2018 | A1 |
20180338767 | Dasnurkar et al. | Nov 2018 | A1 |
20190008522 | Lorenzo | Jan 2019 | A1 |
20190110796 | Jayaraman | Apr 2019 | A1 |
20190142567 | Janardhan et al. | May 2019 | A1 |
20190192162 | Lorenzo | Jun 2019 | A1 |
20190192167 | Lorenzo | Jun 2019 | A1 |
20190192168 | Lorenzo | Jun 2019 | A1 |
20190223878 | Lorenzo | Jul 2019 | A1 |
20190223879 | Jayaraman | Jul 2019 | A1 |
20190223881 | Hewitt et al. | Sep 2019 | A1 |
20190328398 | Lorenzo | Oct 2019 | A1 |
20190357914 | Gorochow | Nov 2019 | A1 |
20190365385 | Gorochow et al. | Dec 2019 | A1 |
20200000477 | Nita et al. | Jan 2020 | A1 |
20200069313 | Xu | Mar 2020 | A1 |
20200268365 | Hebert | Aug 2020 | A1 |
20200375606 | Lorenzo | Dec 2020 | A1 |
20210007755 | Lorenzo et al. | Jan 2021 | A1 |
20210177429 | Lorenzo | Jun 2021 | A1 |
Number | Date | Country |
---|---|---|
2395796 | Jul 2001 | CA |
2 431 594 | Sep 2002 | CA |
2598048 | May 2008 | CA |
204 683 687 | Oct 2015 | CN |
107374688 | Nov 2017 | CN |
102008015781 | Oct 2009 | DE |
102010053111 | Jun 2012 | DE |
102009058132 | Jul 2014 | DE |
10 2013 106031 | Dec 2014 | DE |
202008018523 | Apr 2015 | DE |
102011102955 | May 2018 | DE |
1054635 | Nov 2000 | EP |
1295563 | Mar 2003 | EP |
1441649 | Aug 2004 | EP |
1483009 | Dec 2004 | EP |
1527753 | May 2005 | EP |
1569565 | Sep 2005 | EP |
1574169 | Sep 2005 | EP |
1494619 | Jan 2006 | EP |
1633275 | Mar 2006 | EP |
1659988 | May 2006 | EP |
1725185 | Nov 2006 | EP |
1862122 | Dec 2007 | EP |
1923005 | May 2008 | EP |
2063791 | Jun 2009 | EP |
2134263 | Dec 2009 | EP |
2157937 | Mar 2010 | EP |
2266456 | Dec 2010 | EP |
2324775 | May 2011 | EP |
2367482 | Sep 2011 | EP |
2387951 | Nov 2011 | EP |
2460476 | Jun 2012 | EP |
2468349 | Jun 2012 | EP |
2543345 | Jan 2013 | EP |
2567663 | Mar 2013 | EP |
2617386 | Jul 2013 | EP |
2623039 | Aug 2013 | EP |
2647343 | Oct 2013 | EP |
2848211 | Mar 2015 | EP |
2854704 | Apr 2015 | EP |
2923674 | Sep 2015 | EP |
2926744 | Oct 2015 | EP |
3146916 | Mar 2017 | EP |
3501429 | Jun 2019 | EP |
3517055 | Jul 2019 | EP |
H04-47415 | Apr 1992 | JP |
H07-37200 | Jul 1995 | JP |
2006-509578 | Mar 2006 | JP |
2013-509972 | Mar 2013 | JP |
2013537069 | Sep 2013 | JP |
2014-522268 | Sep 2014 | JP |
2016-502925 | Feb 2015 | JP |
WO 9641589 | Dec 1996 | WO |
WO 9905977 | Feb 1999 | WO |
WO 9908607 | Feb 1999 | WO |
WO 9930640 | Jun 1999 | WO |
WO 2003073961 | Sep 2003 | WO |
WO 03086240 | Oct 2003 | WO |
WO 2005020822 | Mar 2005 | WO |
WO 2005074814 | Aug 2005 | WO |
2005117718 | Dec 2005 | WO |
WO 2006034149 | Mar 2006 | WO |
WO 2006052322 | May 2006 | WO |
2007076480 | Jul 2007 | WO |
WO 2008150346 | Dec 2008 | WO |
WO 2008151204 | Dec 2008 | WO |
WO 2009048700 | Apr 2009 | WO |
WO 2009105365 | Aug 2009 | WO |
WO 2009132045 | Oct 2009 | WO |
WO 2009135166 | Nov 2009 | WO |
WO 2010030991 | Mar 2010 | WO |
WO 2011057002 | May 2011 | WO |
WO 2012032030 | Mar 2012 | WO |
WO-2012034135 | Mar 2012 | WO |
WO 2012099704 | Jul 2012 | WO |
WO 2012099909 | Jul 2012 | WO |
WO 2012113554 | Aug 2012 | WO |
WO 2013016618 | Jan 2013 | WO |
WO 2013025711 | Feb 2013 | WO |
WO 2013109309 | Jul 2013 | WO |
WO 2013159065 | Oct 2013 | WO |
WO 2013162817 | Oct 2013 | WO |
WO 2014029835 | Feb 2014 | WO |
WO 2014078286 | May 2014 | WO |
WO 2014110589 | Jul 2014 | WO |
WO 2014137467 | Sep 2014 | WO |
WO 2015073704 | May 2015 | WO |
2015160721 | Oct 2015 | WO |
2015171268 | Nov 2015 | WO |
WO 2015166013 | Nov 2015 | WO |
WO 2015184075 | Dec 2015 | WO |
WO 2015187196 | Dec 2015 | WO |
WO 2016044647 | Mar 2016 | WO |
WO 2016107357 | Jul 2016 | WO |
WO 2016137997 | Sep 2016 | WO |
WO 2017161283 | Sep 2017 | WO |
WO 2018051187 | Mar 2018 | WO |
WO 2019038293 | Feb 2019 | WO |
Entry |
---|
Extended European Search Report dated May 2, 2019 in corresponding European Application No. 18214052.5. |
Extended European Search Report issued in corresponding European Patent Application No. 19 21 5277 dated May 12, 2020. |
Altes et al., Creation of Saccular Aneurysms in the Rabbit: A Model Suitable for Testing Endovascular Devices. AJR 2000; 174: 349-354. |
Schaffer, Advanced Materials & Processes, Oct. 2002, pp. 51-54. |
Number | Date | Country | |
---|---|---|---|
20210169495 A1 | Jun 2021 | US |